[1]
Zhang, J.X.; Zhang, Y.P.; Wu, Q.N.; Chen, B. Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes. Endocrine, 2015, 48(1), 135-142.
[2]
Maiuolo, J.; Oppedisano, F.; Gratteri, S.; Muscoli, C.; Mollace, V. Regulation of uric acid metabolism and excretion. Int. J. Cardiol., 2016, 213, 8-14.
[3]
Sautin, Y.Y.; Johnson, R.J. Uric acid: The oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids, 2008, 27(6), 608-619.
[4]
Puddu, P.; Puddu, G.M.; Cravero, E.; Vizioli, L.; Muscari, A. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J. Cardiol., 2012, 59(3), 235-242.
[5]
Lin, G.M.; Li, Y.H.; Zheng, N.C.; Lai, C.P.; Lin, C.L.; Wang, J.H.; Jaiteh, L.E.; Han, C.L. Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: Aa prospective observational cohort study from the ET-CHD registry, 1997-2003. J. Cardiol., 2013, 61(2), 122-127.
[6]
Asrih, M.; Jornayvaz, F.R. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Mol. Cell. Endocrinol., 2015, 418(Pt 1), 55-65.
[7]
Chen, S.; Guo, X.; Yu, S.; Zhou, Y.; Li, Z.; Sun, Y. Metabolic syndrome and serum liver enzymes in the general Chinese population. Int. J. Environ. Res. Public Health, 2016, 13(2), 223.
[8]
Liu, Z.; Que, S.; Zhou, L.; Zheng, S. Dose-response rela tionship of serum uric acid with metabolic Syndrome and non-alcoholic fatty liver disease incidence: aA meta-analysis of prospective studies. Sci. Rep., 2015, 5, 14325.
[9]
Yuan, H.; Yu, C.; Li, X.; Sun, L.; Zhu, X.; Zhao, C.; Zhang, Z.; Yang, Z. serum uric acid levels and risk of metabolic syndrome: A dose-response meta-analysis of prospective studies. J. Clin. Endocrinol. Metab., 2015, 100(11), 4198-4207.
[10]
Liu, M.; He, Y.; Jiang, B.; Wu, L.; Yang, S.; Wang, Y.; Li, X. Association between serum uric acid level and metabolic syndrome and its sex difference in a Chinese community elderly population. Int. J. Endocrinol., 2014, 2014, 754678.
[11]
Zhang, H.; Li, Y.; Mao, Z.; Liu, X.; Zhang, X.; Yang, K.; Liu, R.; Qian, X.; Zhang, H.; Jiang, J.; Zhang, G.; Wang, C. Sex-specific associations of serum uric acid with metabolic syndrome in Chinese rural population: The RuralDiab study. Clin. Chim. Acta, 2018, 480, 119-125.
[12]
You, L.; Liu, A.; Wuyun, G.; Wu, H.; Wang, P. Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. J. Atheroscler. Thromb., 2014, 21(4), 355-365.
[13]
Huang, S.; Liu, X.; Li, H.; Xu, W.; Jia, H. Sex difference in the association of serum uric acid with metabolic syndrome and its components: a cross-sectional study in a Chinese Yi population. Postgrad. Med., 2017, 129(8), 828-833.
[14]
Wu, S.J.; Zhu, G.Q.; Ye, B.Z.; Kong, F.Q.; Zheng, Z.X.; Zou, H.; Shi, K.Q.; Lin, L.; Braddock, M.; Huang, W.J.; Chen, Y.P.; Zheng, M.H. Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study. Medicine (Baltimore), 2015, 94(17), e802.
[15]
Lin, G.M.; Li, Y.H.; Lee, C.J.; Shiang, J.C.; Lin, K.H.; Chen, K.W.; Chen, Y.J.; Wu, C.F.; Lin, B.S.; Yu, Y.S.; Lin, F.; Su, F.Y.; Wang, C.H. Rationale and design of the cardiorespiratory fitness and hospitalization events in armed forces study in Eastern Taiwan. World J. Cardiol., 2016, 8(8), 464-471.
[16]
Chen, Y.J.; Chen, K.W.; Shih, Y.L.; Su, F.Y.; Lin, Y.P.; Meng, F.C.; Lin, F.; Yu, Y.S.; Han, C.L.; Wang, C.H.; Lin, J.W.; Hsieh, T.Y.; Li, Y.H.; Lin, G.M. Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study. World J. Gastroenterol., 2017, 23(25), 4587-4594.
[17]
Chen, K.W.; Meng, F.C.; Shih, Y.L.; Su, F.Y.; Lin, Y.P.; Lin, F.; Lin, J.W.; Chang, W.K.; Lee, C.J.; Li, Y.H.; Hsieh, C.B.; Lin, G.M. Sex-specific association between metabolic abnormalities and elevated alanine aminotransferase levels in a military cohort: the CHIEF study. Int. J. Environ. Res. Public Health, 2018, 15(3), pii: E545.
[18]
Zhu, Y.; Pandya, B.J.; Choi, H.K. Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007-2008. Arthritis Rheum., 2011, 63, 3136-3141.
[19]
Ruhl, C.E.; Everhart, J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology, 2003, 124, 71-79.
[20]
Lombardi, R.; Pisano, G.; Fargion, S. Role of serum uric acid and ferritin in the development and progression of NAFLD. Int. J. Mol. Sci., 2016, 17(4), 548.
[21]
Chen, S.; Guo, X.; Zhang, X.; Yu, S.; Yang, H.; Jiang, M.; Sun, G.; Sun, Y. Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study. BMC Cardiovasc. Disord., 2015, 15, 65.
[22]
Brady, C.W. Liver disease in menopause. World J. Gastroenterol., 2015, 21(25), 7613-7620.
[23]
Zelber-Sagi, S.; Ben-Assuli, O.; Rabinowich, L.; Goldstein, A.; Magid, A.; Shalev, V.; Shibolet, O.; Chodick, G. The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort. Liver Int., 2015, 35(11), 2408-2415.
[24]
Hamaguchi, M.; Kojima, T.; Ohbora, A.; Takeda, N.; Fukui, M.; Kato, T. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J. Gastroenterol., 2012, 18(3), 237-243.
[25]
Yang, J.D.; Abdelmalek, M.F.; Pang, H.; Guy, C.D.; Smith, A.D.; Diehl, A.M.; Suzuki, A. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology, 2014, 59(4), 1406-1414.
[26]
Yoneda, M.; Thomas, E.; Sumida, Y.; Eguchi, Y.; Schiff, E.R. The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease. Hepatology, 2014, 60(5), 1792.